Case Comprehensive Cancer Center

Joel Saltzman, MD, a member of Case CCC's Developmental Therapeutic Program and a clinician in the Department of Hematology and Oncology at Cleveland Clinic Taussig Cancer Institute, has been named a Fellow of the American Society of Clinical Oncology (FASCO). An ASCO member is recognized as a fell...

Kaixiang Cao, PhD, a member of Case CCC's Cancer Genomics & Epigenomics program, is challenging the current paradigms for using the LSD1 (lysine-specific histone demethylase 1A) protein to slow cancer growth. He and his team posit that the entire LSD1 protein can be completely degraded rather than t...

Erika Trapl, PhD, Case CCC's Associate Director for Community Outreach and Engagement, Charles Modlin, MD, MBA, Director of the MetroHealth Minority Men's Health Institute, and Waverly Willis, owner/operator of two Urban Kutz barbershops and member of Case CCC's Community Advisory Board, discussed t...

Case Western Reserve biochemists focus on degrading key cancer-driving protein; represents major shift in research Case Western Reserve University biochemical researchers have identified a new function of a key protein that leads to cancer—a finding they believe could lead to more effective treat...

TikToks, apparel design, and science do mix—as the 39 scholars participating in this year's Cancer-focused Summer Undergraduate Research (CanSUR) and the American Cancer Society's Diversity in Cancer Research (ACS-DICR) programs can attest. The programs are directed, respectively, by Mark Jackson, ...

Co-directed by Fred Schumacher, PhD, MPH, co-leader of Case CCC's Population & Cancer Prevention program, and Erika Trapl, PhD, Case CCC's Associate Director of Community Outreach & Engagement, the Healthy Futures Research Project aims to work with the residents of East Palestine and the surrounding...

All eyes—including television cameras—were on the students who participated in the 2023 Student Enrichment Opportunity (SEO) and Youth Engaged in Science (YES) programs. Eighty students from across Cleveland joined Case CCC to work in labs and on projects ranging from cancer health disparities to i...

Case CCC's Associate Director for Cancer Population Sciences, Jennifer Cullen, PhD, MPH, and Alberto Montero, MD, MBA, member of the Developmental Therapeutics Program, address the social determinants of health and racial disparities in cardiac events in breast cancer in an article published in JNCC...

Case CCC sadly shares that Clark Distelhorst, MD, an important and long-standing member, has passed away. An early recruit to the new hematology oncology division established by Nathan Berger, MD, at the CWRU School of Medicine, Distelhorst was appointed a member of the emerging cancer center in 19...

Khalid Sossey-Alaoui, PhD, member of Case CCC's Molecular Oncology Program, received a five-year, $2.3 million grant to study mechanisms mediating "triple-negative" breast cancer and health disparities in African-American women. Among genetically distinct breast cancers, those classified as triple...